Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 11, 2012, Pages 2602-2605

  Van heirstraeten, Liesbet ^a   Leten, Gert ^a   Lammens, Christine ^a   Goossens, Herman ^a   Malhotra kumar, Surbhi ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antibiotic resistance; Group A Streptococcus; Quinolones; S. pyogenes

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BELGIUM; FLUOROQUINOLONE NON SUSCEPTIBILITY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; SCREENING; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BELGIUM; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84867615578     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks281     Document Type: Article

References (16)

1. Malhotra-Kumar S, Lammens C, Chapelle S et al. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 320-5.
2. Montes M, Tamayo E, Orden B et al. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain. Antimicrob Agents Chemother 2010; 54: 93-7.
3. Pires R, Ardanuy C, Rolo D et al. Emergence of ciprofloxacinnonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal. Antimicrob Agents Chemother 2010; 54: 2677-80.
4. Malhotra-Kumar S, Van Heirstraeten L, Lammens C et al. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. J Antimicrob Chemother 2009; 63: 886-94.
5. Billal DS, Fedorko DP, Yan SS et al. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. J Antimicrob Chemother 2007; 59: 28-34.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
7. Yan SS, Fox ML, Holland SM et al. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob Agents Chemother 2000; 44: 3196-8.
8. Smeesters PR, Vergison A, Junior DC et al. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations. Int J Antimicrob Agents 2009; 34: 44-9.
9. Yan SS, Schreckenberger PC, Zheng X et al. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes. Diagn Microbiol Infect Dis 2008; 62: 205-9.
10. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi47-56.
11. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
12. Orscheln RC, Johnson DR, Olson SM et al. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis 2005; 191: 1272-9.
13. Richter SS, Diekema DJ, Heilmann KP et al. Fluoroquinolone resistance in Streptococcus pyogenes. Clin Infect Dis 2003; 36: 380-3.
14. Pletz MW, McGee L, Van Beneden CA et al. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother 2006; 50: 943-8.
15. Arai K, Hirakata Y, Yano H et al. Emergence of fluoroquinoloneresistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution. J Antimicrob Chemother 2011; 66: 494-8.
16. Reinert RR, Lutticken R, Al-Lahham A. High-level fluoroquinolone resistance in a clinical Streptococcus pyogenes isolate in Germany. Clin Microbiol Infect 2004; 10: 659-62.